Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion type Assertion NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_head.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion description "[The resulting chimeric peptide, [Glu(21),Ala(40)][Svg(1-12)]x[human/rat CRF(14-30)]x[Svg(30-40)], named cortagine, was analyzed pharmacologically in cell culture by using human embryonic kidney-293 cells transfected with cDNA coding for CRF(1) or CRF(2), in autoradiographic experiments, and in behavior experiments using male C57BL/6J mice for its modulatory action on anxiety- and depression-like behaviors with the elevated plus-maze test and the forced swim test (FST), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_provenance.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion evidence source_evidence_literature NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_provenance.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion SIO_000772 15192151 NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_provenance.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion wasDerivedFrom befree-20140225 NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_provenance.
- NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_assertion wasGeneratedBy ECO_0000203 NP322770.RAGFUfvTjMag7VnIvr2rwLSllf3L9BZkeZRdo34dEFdgM130_provenance.